Welcome to Explant or Bust!
We’re glad you are here!
Welcome to Explant or Bust! The website title is a bit of a play on words, but reflects the emotions many of us have felt after suffering from Breast Implant Illness (Bii or BII) and Breast Implant Associated (BIA-xxx) cancers. The image that first came to mind was the family station wagon headed for vacation or carpool caravans with the car windows painted with “Destination or Bust!” Explant may be a place you hope to NEVER visit again or an upcoming part of your journey.
Either way, we’re here to help you find reliable information on breast implant safety, explant options, and moral support because YOU ARE NOT ALONE. We are a community of Explanters and Bii Thrivers. So, welcome!
Bii Summit 2024!
I was honored to be a speaker at the Breast Implant Illness Summit 2024! My interview and more information is available on the Breast Implant Illness Summit 2024 post.
Important Allergan & McGhan Textured Saline and Silicone Breast Implant Recall
The FDA finally asked Allergan (formerly McGhan) to voluntarily recall certain macro-textured saline and silicone breast implants that were implicated in causing Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL). McGhan macro-textured breast implants (saline and silicone) are part of this recall.
Allergan Official Important Product Safety Alert of BIOCELL® Textured Breast Implants and Tissue Expanders (external link)
Both macro-textured saline and silicone-filled implants are recalled, because it is the macro-textured surface (not the filling material) that is allegedly causing an autoimmune response which leads to Breast Implant Associated-Anaplastic Large Cell Lymphoma (BIA-ALCL).
To date, there have been no reported cases of smooth implant surfaces causing BIA-ALCL. Breast Implant Associated-Squamous Cell Carcinoma (BIA-SCC) and Breast Implant Associated-B Cell Lymphoma (BIA-BCL) have been associated with BOTH textured and smooth breast implants (World Consensus Conference on BIA-ALCL, 2024).
Recent US FDA Advisories
The following are recent U.S. Food and Drug Administration (US FDA) advisories related to Breast Implant Associated-Squamous Cell Carcinoma (BIA-SCC) cancers caused by both smooth and textured breast implants.
United States Food and Drug Administration (US FDA) Breast Implant Safety Communications (external links below)
- Allergan (McGhan) Voluntarily Recalls BIOCELL® Textured Breast Implants and Tissue Expanders
- U.S. Food & Drug Administration – What to Know About Breast Implants
- U.S. Food & Drug Administration – Risks and Complications of Breast Implants
- FDA takes action to protect patients from risk of certain textured breast implants; requests Allergan voluntarily recall certain breast implants and tissue expanders from market
- U.S. Food & Drug Administration – Medical Device Reports of Breast Implant-Associated Anaplastic Large Cell Lymphoma
- U.S. Food & Drug Administration – Medical Device Reports for Systemic Symptoms in Women with Breast Implants
- U.S. Food & Drug Administration – Labeling for Approved Breast Implants
- U.S. Food & Drug Administration – Questions and Answers about Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL)
- U.S. Food & Drug Administration – MedWatch Online Voluntary Reporting Form
- U.S. Food & Drug Administration – Things to Consider Before Getting Breast Implants
- U.S. Food & Drug Administration – FDA Strengthens Breast Implant Safety Requirements
- U.S. Food & Drug Administration – FDA Strengthens Safety Requirements and Updates Study Results for Breast Implants
- Government of Canada – Health Canada will be Updating Its Safety Review of Breast Implants
- UK Government – Guidance: Breast Implant Associated Anaplastic Large Cell Lymphoma (BIA-ALCL)
- Australian Government – Breast Implants and Anaplastic Large Cell Lymphoma Update – Suspended Breast Implant Devices Now Cancelled
- The 2016 revision of the World Health Organization Classification of Lymphoid Neoplasms
- 5th World Consensus Conference on BIA-ALCL: Recap and Major Takeaways – BISA Article
- An Update on Implant-Associated Malignancies and Their Biocompatibility
Trusted Resources
Breast Implant Safety Alliance (BISA) (external link)
Reversing Breast Implant Illness (external link)
Knowledge is Beautiful.
Breast Implant Safety Alliance
National Breast Implant Registry & Adverse Event Registries
The PROFILE Registry is open to all physicians in the United States who have a patient with breast implants that has a suspected or confirmed case of Breast Implant-Associated ALCL (BIA-ALCL), Breast Implant Associated Squamous Cell Carcinoma (BIA-SCC), Breast Implant Associated-B Cell Lymphoma (BIA-BCL), or any lymphoma or other cancer found in the capsule surrounding the breast implant.
Plastic Surgery Foundation Profile Registry
PROFILE Case Submission Form – Report A Case
National Breast Implant Registry (Medical Device Tracking App)